(Press-News.org) San Diego, CA-- An experimental drug causes loss of weight and fat in mice, a new study has found. The study results will be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
Known as GC-1, the drug reportedly speeds up metabolism, or burning off, of fat cells.
"GC-1 dramatically increases the metabolic rate, essentially converting white fat, which stores excess calories and is associated with obesity and metabolic disease, into a fat like calorie-burning brown fat," said study author Kevin Phillips, PhD, a researcher at Houston Methodist Research Institute, Houston.
Until several years ago, scientists thought that only animals and human infants have energy-burning, "good" brown fat.
"It is now clear," Phillips said, "that human adults do have brown fat, but appear to lose its calorie-burning activity over time."
White adipose tissue, or fat, becomes a "metabolic villain," as Phillips called it, when the body has too much of it. Some published research shows that people who have more brown fat have a reduced risk of obesity and diabetes. Researchers are now working on ways to "brown" white fat, or convert it into brown fat.
GC-1 works, according to Phillips, by activating the receptors for thyroid hormone, which play a role in regulating metabolism--the body's conversion of food into energy. Thyroid hormone receptors also help with adaptive thermogenesis, in which the body converts excess energy (calories and fat) to heat.
Phillips said he and other researchers at Houston Methodist Research Institute have tested the drug in hundreds of mice, with partial research funding from the National Institutes of Health. Obese mice, both genetically obese and those with diet-induced obesity, received GC-1 treatment daily.
Genetically obese mice lost weight and more than 50 percent of their fat mass in approximately two weeks, Phillips reported. Treated mice also showed antidiabetic effects, such as a sixfold improvement or better in insulin sensitivity (how well the body clears glucose from the bloodstream). He said mice with diet-induced obesity experienced similar improvements.
The drug also induced adaptive thermogenesis in fat cells isolated from mice. Cells grown in culture in a dish, as well as tissue samples taken from obese mice, showed evidence of white-fat browning.
"Our data demonstrate that GC-1 is a novel fat-browning agent that may have use in the treatment of obesity and metabolic disease," Phillips said.
The drug has not yet undergone testing for weight loss in humans. GC-1 is being tested in clinical trials for lowering cholesterol, under the name sobetirome. However, Phillips said the doses of sobetirome used in the cholesterol-lowering studies are much lower than what would be needed for weight loss.
INFORMATION:
San Diego, CA-- A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
"Current diagnostic procedures for thyroid cancer often yield uncertain results, leading to recurrent medical procedures and a large number of thyroid surgeries performed unnecessarily," said the study's senior investigator, Donald Bodenner, MD, PhD, chief of endocrine oncology at the University of ...
People with anorexia nervosa and with body dysmorphic disorder have similar abnormalities in their brains that affect their ability to process visual information, a new UCLA study reveals.
People with anorexia have such an intense fear of gaining weight that they starve themselves even when they are dangerously thin. Body dysmorphic disorder is a psychiatric condition characterized by an obsessive preoccupation with a perceived flaw in physical appearance.
The researchers found that people with both disorders had abnormal activity in the visual cortex of the brain during ...
San Diego, CA -- A tooth enamel abnormality in children, molar incisor hypomineralization (MIH), may result from exposure to the industrial chemical bisphenol A (BPA), authors of a new study conclude after finding similar damage to the dental enamel of rats that received BPA. The study results will be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
"Human enamel defects may be used as an early marker of exposure to BPA and similar-acting endocrine disruptors," Babajko said.
BPA is an endocrine disruptor, or hormone-altering chemical, that ...
Herpes simplex virus infections are an enormous global health problem and there is currently no viable vaccine. For nearly three decades, immunologists' efforts to develop a herpes vaccine have centered on exploiting a single protein found on the virus's outer surface that is known to elicit robust production of antibodies. Breaking from this approach, Howard Hughes Medical Institute (HHMI) scientists at Albert Einstein College of Medicine have created a genetic mutant lacking that protein. The result is a powerfully effective vaccine against herpes viruses.
"We have ...
March 10, 2015--(BRONX, NY)--Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes--one of the most common sexually transmitted diseases, affecting some 500 million people worldwide. By using a counterintuitive scientific approach, researchers were able to prevent both active and latent infections caused by herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes. Findings from the research, conducted in mice, were published today in the online ...
San Diego, CA--Exposure to low doses of hormone-disrupting chemicals early in life can alter gene expression in the liver as well as liver function, increasing the susceptibility to obesity and other metabolic diseases in adulthood, a new study finds. Results of the animal study will be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
Brief exposure in infancy to several industrial chemicals that are common in the human environment, particularly bisphenol A (BPA), caused fatty liver disease in adulthood, the researchers found in rats.
"Even ...
San Diego, CA--In patients with chronic heart failure, the vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D), also called calcitriol, and its ratio to parathyroid hormone (PTH 1-84) may help predict cardiovascular death; and patients with decreased calcitriol and decreased ratio of calcitriol to PTH might benefit from more aggressive supplementation, a new study finds. The results will be presented Friday, March 6, at ENDO 2015, the annual meeting of the Endocrine Society in San Diego.
Heart failure, with high morbidity and mortality, is increasingly prevalent ...
San Diego, CA--A treatment known as mindfulness-based stress reduction (MBSR) may decrease fasting glucose and improve quality of life in overweight and obese women, new research suggests. The results will be presented in a poster Friday, March 6, at ENDO 2015, the annual meeting of the Endocrine Society in San Diego.
MBSR is a secular mindfulness meditation program that was developed by Jon Kabat-Zinn, PhD at the University of Massachusetts Medical School. The practice of MBSR involves paying attention to one's thoughts, feelings, and bodily sensations in the present ...
San Diego, CA--A mother's age at childbirth may affect her male baby's birth weight as well as his adult glucose metabolism, new research shows. The results will be presented Friday, March 6, at ENDO 2015, the annual meeting of the Endocrine Society in San Diego.
"Our findings indicate that women giving birth at a very young (under 25 years) or older (over 34 years) age might result in less favorable sugar handling and thus possibly higher risk for developing type 2 diabetes in their sons," said Charlotte Verroken, MD, of the Department of Endocrinology of Ghent University ...
(MEMPHIS, Tenn. - March 6, 2015) The St. Jude Children's Research Hospital--Washington University Pediatric Cancer Genome Project reports that a highly aggressive form of leukemia in infants has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene. The findings suggest that targeting the alteration is likely the key to improved survival. The research appeared online ahead of print this week in the scientific journal Nature Genetics.
The study is the most comprehensive analysis yet of this rare but aggressive subtype of pediatric acute ...
